Literature DB >> 15060350

Migration studies and histology of injectable microspheres of different sizes in mice.

Gottfried Lemperle1, Vera B Morhenn, Vasumati Pestonjamasp, Richard L Gallo.   

Abstract

Injectable dermal filler materials consist of either fluids, biological fragments, or suspensions of particles or microspheres. Particles and microspheres are said to "migrate," but migration can occur only when they are injected into blood vessels. To evaluate biocompatibility and transport, five nonresorbable polymethylmethacrylate microspheres of various sizes, suspended in different carriers, as well as resorbable polylactic acid and dextran microspheres were injected subcutaneously into mice. The five implantation sites were the right cheek, right axilla, right groin, urethra, and the right quadriceps muscle of the thigh. These sites were excised along with the local lymph nodes, lungs, liver, and spleen at 1, 3, 6, and 9 months after injection. Polymethylmethacrylate microspheres of 4 microm and 8 microm were phagocytosed but not transported to lymph nodes or distant organs. Larger microspheres of 20, 40, and 100 microm were encapsulated by connective tissue, macrophages, and giant cells. Polylactic acid microspheres caused a mild inflammatory response and had disappeared at 6 months. Dextran microspheres caused a pronounced foreign-body reaction and were phagocytosed at 9 months. The extremely large carbon-coated spheres of 200 to 500 microm in diameter "migrated" up to 1 cm from the implantation site. With the exception of an erroneous intravenous injection, no migration or transportation of any of the injected microspheres to lymph nodes or filter organs was seen. Obviously, the collagen glue released no microspheres. After subdermal injection, the collagen carrier substance kept the microspheres apart as a scaffold for tissue ingrowth, whereas all other carrier substances, such as gelatin, hyaluronic acid, or alginate, separated soon after injection, thereby causing agglomeration of the microspheres.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060350     DOI: 10.1097/01.prs.0000112764.22839.7a

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  18 in total

1.  Global Volumetric Assessment and Three-Dimensional Enhancement of the Face With Injectable Poly-L-lactic Acid.

Authors:  Richard N Sherman
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 2.  The use of micro- and nanospheres as functional components for bone tissue regeneration.

Authors:  Huanan Wang; Sander C G Leeuwenburgh; Yubao Li; John A Jansen
Journal:  Tissue Eng Part B Rev       Date:  2011-09-23       Impact factor: 6.389

3.  Optimizing injectable poly-L-lactic acid administration for soft tissue augmentation: The rationale for three treatment sessions.

Authors:  Ute Bauer; Miles H Graivier
Journal:  Can J Plast Surg       Date:  2011

4.  Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.

Authors:  Elena Tous; Heather M Weber; Myung Han Lee; Kevin J Koomalsingh; Takashi Shuto; Norihiro Kondo; Joseph H Gorman; Daeyeon Lee; Robert C Gorman; Jason A Burdick
Journal:  Acta Biomater       Date:  2012-05-29       Impact factor: 8.947

5.  NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.

Authors:  Daniel Hänggi; Nima Etminan; R Loch Macdonald; Hans Jakob Steiger; Stephan A Mayer; Francois Aldrich; Michael N Diringer; Brian L Hoh; J Mocco; Poul Strange; Herbert J Faleck; Michael Miller
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

6.  Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.

Authors:  Rebecca Voltan; Arianna Castaldello; Egidio Brocca-Cofano; Giuseppe Altavilla; Antonella Caputo; Michele Laus; Katia Sparnacci; Barbara Ensoli; Silvia Spaccasassi; Marco Ballestri; Luisa Tondelli
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

7.  ArteFill permanent injectable for soft tissue augmentation: II. Indications and applications.

Authors:  Gottfried Lemperle; Neil S Sadick; Terry R Knapp; Stefan M Lemperle
Journal:  Aesthetic Plast Surg       Date:  2009-09-29       Impact factor: 2.326

8.  Endoscopic augmentation of the esophagogastric junction with polymethylmethacrylate: durability, safety, and efficacy after 6 months in mini-pigs.

Authors:  Fernando Fornari; Carmen P F Freitag; Marcos E S Duarte; Cleber R P Kruel; Paulo R O Thomé; Paulo R S Sanches; Luise Meurer; Carlos T Z Cerski; Cesar Liberato Petzhold; Sidia M Callegari-Jacques; Sérgio G S Barros
Journal:  Surg Endosc       Date:  2009-02-28       Impact factor: 4.584

9.  Immediate nor Delayed Type Hypersensitivity Plays a Role in Late Inflammatory Reactions After Hyaluronic Acid Filler Injections.

Authors:  Tom Decates; Jonathan Kadouch; Peter Velthuis; Thomas Rustemeyer
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-05-31

10.  ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques.

Authors:  Gottfried Lemperle; Terry R Knapp; Neil S Sadick; Stefan M Lemperle
Journal:  Aesthetic Plast Surg       Date:  2009-09-29       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.